LIVE: Reuters NEXT Newsmaker with EMA Executive Director Emer Cooke
TL;DR
EMA Executive Director Emer Cooke defends Europe's life sciences sector against claims of falling behind the US and China, emphasizing new regulatory frameworks and industry engagement, while warning that US drug pricing policies threaten to delay launches and limit patient access to new medicines including weight loss pills expected by summer.
🔬 Europe's Innovation Landscape 3 insights
Defending European competitiveness
Cooke rejects narratives of European decline, citing active implementation of new pharma legislation, the Biotech Act, and Critical Medicines Act to boost innovation and competitiveness.
Regulatory modernization efforts
EMA is deploying "sandbox" regulatory approaches and platform technologies ahead of formal legislation while engaging directly with biotech clusters to connect innovators with financing.
Industry collaboration initiative
The agency recently convened 24 pharmaceutical companies to discuss leveraging Europe's strengths in data digitalization and AI to attract R&D investment.
💶 Drug Access and Pricing Pressures 3 insights
US pricing impact on launches
Cooke warns that US international reference pricing policies have contributed to a 35% drop in EU drug launches, potentially delaying access to breakthrough treatments for European patients.
Calls for unified procurement
To counter fragmented national markets, she advocates for "more Europe" through joint procurement mechanisms in the Critical Medicines Act, creating larger, more attractive markets for manufacturers.
Weight loss pill timeline
Regulatory decisions on oral GLP-1 weight loss medications from Novo Nordisk and Eli Lilly are expected by summer.
🌐 Global Regulatory Dynamics 3 insights
Continued FDA collaboration
Despite Trump administration leadership changes, EMA maintains daily contact with FDA colleagues and recently published joint AI principles while restarting staff exchange programs.
Scientific talent migration
Cooke notes anecdotal evidence of US scientists and former FDA staff relocating to European institutions amid American research funding uncertainties, positioning Europe as stable and predictable.
China engagement strategy
While acknowledging record Chinese biotech licensing deals, she admits few applications currently reach EMA despite impressive regulatory improvements in China.
⚕️ Supply Security and Shortages 2 insights
Antibiotic shortage reduction
Using new 2023 legal powers, EMA's Medicine Shortage Steering Group reduced antibiotic shortages by over 50% through proactive supply-and-demand monitoring after COVID disruptions.
Emergency preparedness limitations
Cooke acknowledges Europe likely cannot produce vaccines within six months of a new health emergency, citing the 10-12 month COVID timeline as the realistic standard even with unprecedented collaboration.
Bottom Line
Europe must adopt centralized procurement and unified market approaches to remain competitive for drug launches, as fragmented national pricing increasingly drives manufacturers to prioritize the US and China while threatening patient access.
More from Reuters
View all
LIVE: Pope Leo continues visit to Spain
Pope Leo XIV continues his visit to Spain with a historic address to the Congress of Deputies, becoming the first pontiff to speak before the lower house of the Spanish parliament, alongside diplomatic meetings with government leaders to discuss global conflicts and wars.
LIVE: WHO, Africa CDC officials hold virtual briefing on Ebola outbreak
WHO and Africa CDC launched a joint $518 million continental plan to contain the rapidly expanding Ebola outbreak in the DRC and Uganda, as confirmed cases reached 397 with a 16% fatality rate, making it the most serious Sudan ebolavirus outbreak recorded to date.
LIVE: President Trump expected to make coal announcement
President Trump announced the invocation of the Defense Production Act to rescue 13 coal plants across ten states, alongside plans for new mining permits, expanded federal leasing, and the first new coal plant construction since 2013, reversing the previous administration's energy policies.
LIVE: Olympic committee officials hold a briefing in LA
With 771 days until the 2028 Olympics, IOC and LA28 officials confirmed the games have shifted from planning to operational readiness, citing record $2 billion in commercial revenue, 4 million tickets sold, and a break-even budget that protects local taxpayers from bearing any costs.